MAIA Pharmaceuticals
Specializing in innovative and niche generic products for injectables, diagnostics, hormones, and oncology since 2013.
Specializing in innovative and niche generic products for injectables, diagnostics, hormones, and oncology since 2013.
MAIA Pharmaceuticals is a biopharmaceutical company based in Princeton, New Jersey, specializing in the development and production of innovative and niche generic products for injectables, diagnostics, hormones, and oncology. Established in 2013, the company has garnered attention for its expertise in the field, leading to a notable $845.00K Seed Round investment on 29 October 2014. This investment reflects the confidence of the stakeholders in the company's potential to make significant strides in the health and wellness, manufacturing, and pharmaceutical industries. MAIA Pharmaceuticals' commitment to bringing specialized generic products to the market underscores its potential for growth and impact within the pharmaceutical sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $845.00K | - | 29 Oct 2014 |
No recent news or press coverage available for MAIA Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
